Consultation documents.
- Published in:
- 2007
- Publication type:
- Journal Article
Works matching IS 10109609 AND DT 2007 AND VI 21 AND IP 3
Results: 36
1
2
Pharmacovigilance focus.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
3
PLoS Neglected Tropical Diseases open access journal.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 246
- Publication type:
- Article
4
Priorities for dengue control.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 246
- Publication type:
- Article
5
Untangling the web: tenth edition.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 245
- Publication type:
- Article
6
Pharmacogenomics guidance from Health Canada.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 245
- Publication type:
- Article
7
Nevirapine tablets.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 241
- Publication type:
- Article
8
Nevirapine oral solution.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 238
- Publication type:
- Article
9
Efavirenz capsules.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 235
- Publication type:
- Article
10
Rifampicin, isoniazid and pyrazinamide dispersible tablets.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 232
- Publication type:
- Article
11
Rifampicin and Isoniazid dispersible tablets.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 229
- Publication type:
- Article
12
Rifampicin, isoniazid and ethambutol hydrochloride tablets.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 226
- Publication type:
- Article
13
Quinine sulfate tablets.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 223
- Publication type:
- Article
14
Sulfadoxine and pyrimethamine tablets.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 221
- Publication type:
- Article
15
Paediatric artemether and lumefantrine oral suspension.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 216
- Publication type:
- Article
16
Chloroquine sulfate oral solution.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 214
- Publication type:
- Article
17
Amodiaquine hydrochloride tablets.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 212
- Publication type:
- Article
18
Global strategy to prevent transmission of Chagas disease.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 211
- Publication type:
- Article
19
Withdrawal of products containing veralipride.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 210
- Publication type:
- Article
20
Tegaserod temporarily suspended.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 210
- Publication type:
- Article
21
Nimesulide: suspension following liver failure.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 209
- Publication type:
- Article
22
Viracept: suspension pending quality and safety assessment.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 208
- Publication type:
- Article
23
Pioglitazone: fractures in women.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 207
- Publication type:
- Article
24
Vinca alkaloids: intravenous administration.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 207
- Publication type:
- Article
25
Omalizumab and anaphylaxis.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 207
- Publication type:
- Article
26
Cinacalcet: indication changes.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 206
- Publication type:
- Article
27
Rosiglitazone and parotid gland enlargement.
- Published in:
- 2007
- Publication type:
- Excerpt
28
NSAIDS and cardiovascular risk.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 205
- Publication type:
- Article
29
Bevacizumab: tracheoesophageal fistula.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 204
- Publication type:
- Article
30
Rosiglitazone: cardiovascular safety profile.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 204
- Publication type:
- Article
31
Rosiglitazone: cardiac safety.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 203
- Publication type:
- Article
32
WHO pharmacovigilance capacity building.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 202
- Publication type:
- Article
33
A vital link in the patient safety chain.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 198
- Publication type:
- Article
34
Educational modules for health professionals reporting adverse reactions.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 197
- Publication type:
- Article
35
Adverse reaction reporting in Canada.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 197
- Publication type:
- Article
36
Challenges of pharmaco-vigilance in Ukraine.
- Published in:
- WHO Drug Information, 2007, v. 21, n. 3, p. 193
- Publication type:
- Article